Skip to content

Compressive of blood glucose between 2 sedative drugs Midazolam and Propofol in implant surgery

Compressive evaluation of change of blood glucose during sedation with Midazolam and Propofol in implant surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201303144224N20
Enrollment
32
Registered
2013-07-24
Start date
2013-04-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood glucose. Elevated blood glucose level

Interventions

Admistartion1 drug regime to 1 patients groups: 25µg/kg/min propofol (Dongkook pharma Co, Korea) by infusion pomp.
Intervention 1: Admistartion1 drug regime to 1 patients groups: One milligram midazolam (Tehran Chemie Pharmaceutical co, Iran) inject and when needed, it repeat every 2 minutes until the patient ent
Treatment - Drugs
Admistartion1 drug regime to 1 patients groups: One milligram midazolam (Tehran Chemie Pharmaceutical co, Iran) inject and when needed, it repeat every 2 minutes until the patient entered the sedated

Sponsors

vice chancellor for Research of Isfahan university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: ASA I,II? Age between 35-60 years? No diabetes disease? Not intake Corton? Having satisfaction about sedation and blood glucose measurement? Need 2 or 3 implant? No contraindication of use of Midazolam and Propofol. Exclusion Criteria: No patient satisfaction? Need to bone or sinus surgery? Systemic disease? Problem during surgery? Time of surgery over than 90 minutes.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood glucose. Timepoint: in 4 different times during surgery. Method of measurement: Acuu chek system.

Secondary

MeasureTime frame
Anxiety. Timepoint: one time before surgery. Method of measurement: according to DAS scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina Shahtoosi

Dental school of Isfahan medical sciences

m.shahtusi@gmail.com+98 31 1792 2858

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026